claim: eli lilly can produce up to 10 million doses of covid-19 antibody drug this year if allowed by fda
evidence_1: enlarge this image the food and drug administration has authorized eli lilly's antibody-based drug bamlanivimab for emergency use as a treatment for covid-19.", "lilly is testing both single antibody therapy as well as combinations of antibodies as potential therapeutics for covid-19.")